[{"address1": "11250 El Camino Real", "address2": "Suite 100", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 410 0266", "website": "https://skyebioscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Mr. Punit S. Dhillon B.A.", "age": 44, "title": "President, CEO, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 714096, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kaitlyn Melanie Arsenault CPA", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 503361, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tu  Diep M.Sc.", "age": 43, "title": "Chief Operating Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 475512, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher G. Twitty Ph.D.", "age": 52, "title": "Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brennen  Brodersen J.D.", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Puneet S. Arora FACE, M.D., M.S.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 10, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.6, "open": 3.6, "dayLow": 3.505, "dayHigh": 4.1599, "regularMarketPreviousClose": 3.6, "regularMarketOpen": 3.6, "regularMarketDayLow": 3.505, "regularMarketDayHigh": 4.1599, "payoutRatio": 0.0, "beta": 2.343, "forwardPE": -3.5431037, "volume": 771998, "regularMarketVolume": 771998, "averageVolume": 446019, "averageVolume10days": 401970, "averageDailyVolume10Day": 401970, "bid": 4.07, "ask": 4.16, "bidSize": 1, "askSize": 1, "marketCap": 127362408, "fiftyTwoWeekLow": 1.14, "fiftyTwoWeekHigh": 5.96, "allTimeHigh": 1937.5, "allTimeLow": 1.14, "fiftyDayAverage": 3.7083, "twoHundredDayAverage": 2.873675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 79144664, "profitMargins": 0.0, "floatShares": 18620012, "sharesOutstanding": 30988420, "sharesShort": 2745750, "sharesShortPriorMonth": 2669234, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.088599995, "heldPercentInsiders": 0.01442, "heldPercentInstitutions": 0.66056, "shortRatio": 8.84, "shortPercentOfFloat": 0.1331, "impliedSharesOutstanding": 30988420, "bookValue": 1.409, "priceToBook": 2.9169624, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -42372968, "trailingEps": -1.06, "forwardEps": -1.16, "lastSplitFactor": "1:250", "lastSplitDate": 1694131200, "enterpriseToEbitda": -1.757, "52WeekChange": 0.051150918, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 4.11, "targetHighPrice": 20.0, "targetLowPrice": 10.0, "targetMeanPrice": 14.28571, "targetMedianPrice": 14.0, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 48585284, "totalCashPerShare": 1.568, "ebitda": -45034848, "totalDebt": 367540, "quickRatio": 5.847, "currentRatio": 6.086, "debtToEquity": 0.842, "returnOnAssets": -0.40919, "returnOnEquity": -0.72752, "freeCashflow": -11517848, "operatingCashflow": -33367488, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SKYE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Skye Bioscience, Inc.", "longName": "Skye Bioscience, Inc.", "regularMarketChangePercent": 14.1667, "regularMarketPrice": 4.11, "corporateActions": [], "postMarketTime": 1758930951, "regularMarketTime": 1758916800, "exchange": "NGM", "messageBoardId": "finmb_266974060", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1420554600000, "postMarketChangePercent": -1.45985, "postMarketPrice": 4.05, "postMarketChange": -0.0599999, "regularMarketChange": 0.51, "regularMarketDayRange": "3.505 - 4.1599", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 446019, "fiftyTwoWeekLowChange": 2.9700003, "fiftyTwoWeekLowChangePercent": 2.6052635, "fiftyTwoWeekRange": "1.14 - 5.96", "fiftyTwoWeekHighChange": -1.8499999, "fiftyTwoWeekHighChangePercent": -0.31040266, "fiftyTwoWeekChangePercent": 5.115092, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.06, "epsForward": -1.16, "epsCurrentYear": -1.34333, "priceEpsCurrentYear": -3.059561, "fiftyDayAverageChange": 0.40170002, "fiftyDayAverageChangePercent": 0.10832457, "twoHundredDayAverageChange": 1.236325, "twoHundredDayAverageChangePercent": 0.43022436, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-04-11", "prevName": "Emerald Bioscience Inc.", "nameChangeDate": "2025-09-26", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Skye Bioscience", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]